XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Significant Accounting Policies - Net Loss Per Share (Details) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Summary of Significant Accounting Polices        
Exercise price of warrants (in dollars per share) $ 8.03   $ 8.03  
Anti-dilutive securities excluded from the calculation of diluted net loss per share (in shares) 23,512,339 18,545,557 23,512,339 18,545,557
Employee Stock Option        
Summary of Significant Accounting Polices        
Anti-dilutive securities excluded from the calculation of diluted net loss per share (in shares) 11,531,468 6,564,686 11,531,468 6,564,686
Common stock warrants        
Summary of Significant Accounting Polices        
Anti-dilutive securities excluded from the calculation of diluted net loss per share (in shares) 6,796,280 6,796,280 6,796,280 6,796,280
Series X Preferred Stock        
Summary of Significant Accounting Polices        
Anti-dilutive securities excluded from the calculation of diluted net loss per share (in shares) 5,184,591 5,184,591 5,184,591 5,184,591
Pre-funded warrants        
Summary of Significant Accounting Polices        
Number of warrants to purchase common stock 1,571,093   1,571,093  
Exercise price of warrants (in dollars per share) $ 0.001   $ 0.001